197 related articles for article (PubMed ID: 6189225)
21. Studies on the mechanism of inhibition of natural killer cell mediated cytotoxicity by non-cytotoxic (inert) lymphocytes.
Saxena RK
Indian J Exp Biol; 1981 Sep; 19(9):812-8. PubMed ID: 7309168
[No Abstract] [Full Text] [Related]
22. Phorbolester-treated human lymphocytes are susceptible to natural killer cell-mediated cytolysis.
Kabelitz D; Kunkel HG
J Immunol; 1983 Jun; 130(6):2505-7. PubMed ID: 6189890
[TBL] [Abstract][Full Text] [Related]
23. Role of natural killer cells in virus infections of mice.
Welsh RM; Biron CA; Bukowski JF; McIntyre KW; Yang H
Surv Synth Pathol Res; 1984; 3(5):409-31. PubMed ID: 6084280
[No Abstract] [Full Text] [Related]
24. Interferon and natural killer (NK) cells.
Herberman RB; Ortaldo JR; Timonen T; Reynolds CW; Djeu JY; Pestka S; Stanton J
Tex Rep Biol Med; 1981-1982; 41():590-5. PubMed ID: 6189224
[No Abstract] [Full Text] [Related]
25. Imatinib mesylate--uncovering a fast track to adaptive immunity.
Smyth MJ
N Engl J Med; 2006 May; 354(21):2282-4. PubMed ID: 16723621
[No Abstract] [Full Text] [Related]
26. Natural cell-mediated immunity during viral infections.
Welsh RM
Curr Top Microbiol Immunol; 1981; 92():83-106. PubMed ID: 6171387
[No Abstract] [Full Text] [Related]
27. [Lymphocyte cytotoxicity].
Govaerts A
Bull Mem Acad R Med Belg; 1977; 132(7-8):412-22. PubMed ID: 306265
[No Abstract] [Full Text] [Related]
28. [Natural killer cells].
Engler H; Kirchner H
Med Monatsschr Pharm; 1983 Jan; 6(1):3-10. PubMed ID: 6186898
[No Abstract] [Full Text] [Related]
29. [Cytotoxic activity of lymphoid cells in cancer].
Kamenetz LIa; Grinevich IuA
Vopr Onkol; 1980; 26(7):81-6. PubMed ID: 6996321
[No Abstract] [Full Text] [Related]
30. Generation of natural killer-like cytotoxicity from human thymocytes with interleukin-2.
Gray JD; Torten M; Golub SH
Nat Immun Cell Growth Regul; 1983-1984; 3(3):124-33. PubMed ID: 6209571
[TBL] [Abstract][Full Text] [Related]
31. Is it a DC, is it an NK? No, it's an IKDC.
Shortman K; Villadangos JA
Nat Med; 2006 Feb; 12(2):167-8. PubMed ID: 16462794
[No Abstract] [Full Text] [Related]
32. [Lymphocyte subpopulations in malignant growths].
Kadagidze ZG
Vopr Onkol; 1984; 30(1):90-7. PubMed ID: 6198804
[No Abstract] [Full Text] [Related]
33. Several aspects of natural killer cell-mediated cytotoxicity in normal individuals and cancer patients.
Lotzová E
Cell Mol Biol Incl Cyto Enzymol; 1980; 26(4):423-31. PubMed ID: 6159979
[No Abstract] [Full Text] [Related]
34. Lymphocyte-mediated cytolysis and disease.
Liu CC; Young LH; Young JD
N Engl J Med; 1996 Nov; 335(22):1651-9. PubMed ID: 8929363
[No Abstract] [Full Text] [Related]
35. Procedures for the mixed lymphocyte reaction and cell-mediated lympholysis.
Heron I; Berg K
Methods Enzymol; 1981; 79(Pt B):484-93. PubMed ID: 6173697
[No Abstract] [Full Text] [Related]
36. [Innate nonspecific antiviral immunity].
Błach-Olszewska Z
Postepy Hig Med Dosw; 1999; 53(1):3-21. PubMed ID: 10352544
[TBL] [Abstract][Full Text] [Related]
37. [Signal slitting as a basis of involvement of the natural cytotoxicity system into endogenous biological relay].
Cheknev SB
Biull Eksp Biol Med; 1999 Dec; 128(12):604-12. PubMed ID: 10650453
[No Abstract] [Full Text] [Related]
38. Exposing tumor cells to killer cell attack.
Watzl C; Long EO
Nat Med; 2000 Aug; 6(8):867-8. PubMed ID: 10932221
[No Abstract] [Full Text] [Related]
39. Fever, interleukin-1 and host defense against malignancy.
Dinarello CA; Dempsey RA; Mier JW; Rosenwasser LJ; Parkinson DR
Lymphokine Res; 1982; 1(3):59-67. PubMed ID: 6083420
[No Abstract] [Full Text] [Related]
40. The influence of general anesthesia and surgery on cell-mediated cytotoxicity and interferon production.
Møller-Larsen F; Møller-Larsen A; Haahr S
J Clin Lab Immunol; 1983 Oct; 12(2):69-75. PubMed ID: 6196485
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
